854018-87-4

Basic information

• Product Name: 4-Chloro-2-Methyl-1H-pyrrolo[3,2-c]pyridine
• Synonyms: 4-Chloro-2-Methyl-5-azaindole;4-Chloro-2-Methyl-1H-pyrrolo[3,2-c]pyridine
• CAS NO: 854018-87-4
• Molecular Formula: C₈H₇ClN₂
• Molecular Weight: 166.60758
• Mol File: 854018-87-4.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 310.6±37.0 °C(Predicted)
• Appearance: /
• Density: 1.351±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 14.87±0.40(Predicted)
• CAS DataBase Reference: 4-Chloro-2-Methyl-1H-pyrrolo[3,2-c]pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Chloro-2-Methyl-1H-pyrrolo[3,2-c]pyridine(854018-87-4)
• EPA Substance Registry System: 4-Chloro-2-Methyl-1H-pyrrolo[3,2-c]pyridine(854018-87-4)

Safety Data

• Hazardous Substances Data: 854018-87-4(Hazardous Substances Data)

Usage

General Description

4-Chloro-2-Methyl-1H-pyrrolo[3,2-c]pyridine is a chemical compound categorized under the group of pyrrolopyridines. It has a molecular weight of 180.590 g/mol. It is characterized by the presence of a pyrrolopyridine core, which is a bicyclic unit composed of a pyrrole fused to a pyridine, having a chlorine atom and a methyl group at different positions within this structure. Its exact molecular formula is C9H8ClN2. This chemical is used for various scientific purposes, potentially including pharmaceutical research due to the pharmacologically relevant pyrrolopyridine moiety in its structure. Information regarding its hazards or potential safety concerns is not readily available, suggesting that it may need handling with the usual precautions that should be applied to any chemicals.

Upstream product

• 854018-86-3 tert-butyl (2-chloro-3-prop-1-yn-1-ylpyridin-4-yl)carbamate 
• 14432-12-3 4-Amino-2-chloropyridine 
• 234108-74-8 (2-chloro-3-iodo-pyridin-4-yl)-carbamic acid tert-butyl ester 
• 909036-46-0 2-chloro-3-iodo-pyridin-4-ylamine 
• 234108-73-7 (2-chloro-pyridin-4-yl)-carbamic acid tert-butyl ester 

Downstream Products

• 854018-88-5 4-chloro-3-(4-chloro-phenylsulfanyl)-2-methyl-1H-pyrrolo[3,2-c]pyridine 
• 1415043-75-2 {2-Methyl-4-oxo-3-[2-(phenylsulfonyl)benzyl]-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-1-yl}acetic acid 
• 1415043-76-3 Ethyl {2-methyl-4-oxo-3-[2-(phenylsulfonyl)benzyl]-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-1-yl}acetate 
• 1415043-77-4 Ethyl {2,5-dimethyl-4-oxo-3-[2-(phenylsulfonyl)benzyl]-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-1-yl}acetate 
• 1415043-78-5 {2,5-Dimethyl-4-oxo-3-[2-(phenylsulfonyl)benzyl]-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-1-yl}acetic acid 
• 1415043-79-6 Ethyl {5-(difluoromethyl)-2-methyl-4-oxo-3-[2-(phenylsulfonyl)benzyl]-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-1-yl}acetate 
• 1415043-80-9 {5-(Difluoromethyl)-2-methyl-4-oxo-3-[2-(phenylsulfonyl)benzyl]-4,5-dihydro-1H-pyrrolo[3,2-c]pyridin-1-yl}acetic acid 
• 1415043-04-7 ethyl {4-chloro-2-methyl-3-[2-(phenylsulfonyl)benzyl]-1H-pyrrolo[3,2-c]pyridin-1-yl}acetate 
• 1415043-03-6 4-Chloro-2-methyl-3-[2-(phenylsulfonyl)benzyl]-1H-pyrrolo[3,2-c]pyridine 
• 1420070-44-5 ethyl {4-chloro-3-[2-{[(cyclopropylcarbonyl)(ethyl)amino]methyl}-4-(trifluoromethyl)phenyl]-2-methyl-1H-pyrrolo[3,2-c]pyridin-1-yl}acetate 
• 1420070-45-6 ethyl {3-[2-{[(cyclopropylcarbonyl)(ethyl)amino]methyl}-4-(trifluoromethyl)phenyl]-2,4-dimethyl-1H-pyrrolo[3,2-c]pyridin-1-yl}acetate 
• 1420071-10-8 {3-[2-{[(cyclopropylcarbonyl)(ethyl)amino]methyl}-4-(trifluoromethyl)phenyl]-2,4-dimethyl-1H-pyrrolo[3,2-c]pyridin-1-yl}acetic acid 
• 871327-76-3 4-chloro-3-[(4-chlorophenyl)thio]-2-methyl-1H-pyrrolo[3,2-c]pyridine-1-acetic acid 1,1-dimethylethyl ester 
• 871327-78-5 [4-chloro-3-(4-chloro-phenylsulfonyl)-2-methyl-pyrrolo[3,2-c]pyridin-1-yl]-acetic acid ethyl ester 

Relevant articles and documents

New CRTh2 antagonists

The present invention relates to compounds of formula (I), to the process for preparing such compounds and to their use in the treatment of a pathological condition or disease susceptible to amelioration by CRTh2 antagonist activity.

New CRTH2 Antagonists

The present invention relates to a compound of formula (I), to the process for preparing such compounds and to their use in the treatment of a pathological condition or disease susceptible to amelioration by CRTh2 antagonist activity.

1-ACETIC ACID-INDOLE, -INDAZOLE AND-BENZIMIDAZOLE DERIVATIVES USFUL FOR THE TREATMENT OF RESPIRATORY DISORDERS

The present invention relates to substituted indoles of formula (I) useful as pharmaceutical compounds for treating respiratory disorders.